zyprexa intramuscular

Generic: olanzapine

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name zyprexa intramuscular
Generic Name olanzapine
Labeler eli lilly and company
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

olanzapine 10 mg/2mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-7597
Product ID 0002-7597_9073f34c-307c-4a3a-8273-580ef5742229
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021253
Marketing Start 2004-04-01
Marketing End 2026-06-30

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00027597
Hyphenated Format 0002-7597

Supplemental Identifiers

RxCUI
153046 153047 153048 200034 212405 261337 283639 284514 312076 312077 312078 312079 314154 314155 351107 351108 485968 545353 754503 754504 754505 754506
UPC
0300024415300 0300024116306 0300024115309 0300024420304 0300024112308 0300024117303
UNII
N7U69T4SZR
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zyprexa intramuscular (source: ndc)
Generic Name olanzapine (source: ndc)
Application Number NDA021253 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 10 mg/2mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0002-7597-01) / 2 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

olanzapine (10 mg/2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "9073f34c-307c-4a3a-8273-580ef5742229", "openfda": {"nui": ["N0000175430"], "upc": ["0300024415300", "0300024116306", "0300024115309", "0300024420304", "0300024112308", "0300024117303"], "unii": ["N7U69T4SZR"], "rxcui": ["153046", "153047", "153048", "200034", "212405", "261337", "283639", "284514", "312076", "312077", "312078", "312079", "314154", "314155", "351107", "351108", "485968", "545353", "754503", "754504", "754505", "754506"], "spl_set_id": ["d5051fbc-846b-4946-82df-341fb1216341"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0002-7597-01)  / 2 mL in 1 VIAL", "package_ndc": "0002-7597-01", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}], "brand_name": "ZYPREXA Intramuscular", "product_id": "0002-7597_9073f34c-307c-4a3a-8273-580ef5742229", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "0002-7597", "generic_name": "Olanzapine", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZYPREXA", "brand_name_suffix": "Intramuscular", "active_ingredients": [{"name": "OLANZAPINE", "strength": "10 mg/2mL"}], "application_number": "NDA021253", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20040401"}